UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference
May 30, 2017 12:12 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 30, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology,...
UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference
May 30, 2017 12:12 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 30, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology,...
UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference
May 30, 2017 12:12 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 30, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology,...
UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference
May 30, 2017 12:12 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 30, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology,...
UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference
May 30, 2017 12:12 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 30, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology,...
UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference
May 30, 2017 12:12 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 30, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology,...
UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference
May 30, 2017 12:12 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 30, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology,...